Evidence map›Paper›PMID 35122179›Full record

ArticleInflammation2022

Dynamic Changes of NCR

Jiayu Cai, Hongyan Lu, Zhaoliang Su, Lanlan Mi, Suqing Xu, Zhengyang Xue

Open access · hybridAbstract read
In one paragraph

Article in Inflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Observational
  5. Article
  6. Mediators of inflammation · 2024
    Article
  7. Article
  8. Article
  9. ILC3: a case of conflicted identity.Frontiers in immunology · 2023
    Review
  10. Association of immune cell recruitment and BPD development.Molecular and cellular pediatrics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jiayu CaiDepartment of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China.
Hongyan LuDepartment of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China. lhy5154@163.com.ORCID http://orcid.org/0000-0003-4367-2715
Zhaoliang SuLaboratory of Immunopharmacology, Jiangsu University, Zhenjiang, Jiangsu, 212000, China.
Lanlan MiDepartment of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China.
Suqing XuDepartment of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China.
Zhengyang XueDepartment of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China.
Jiangsu University · CN

Funding

Innovative Research Group Project of the National Natural Science Foundation of China 81741052
6 · The paper itself

Abstract

Inflammation is one of the important pathogenesis of bronchopulmonary dysplasia (BPD). Type 3 innate lymphoid cells (ILC3) play a role in a variety of inflammatory lung diseases. In this study, we established the BPD model by injecting lipopolysaccharide into the amniotic cavity of pregnant mice. Here, we investigated the dynamic changes of ILC3 and NKP46

Indexed as

Bronchopulmonary DysplasiaAnimalsCytokinesFemaleHumansImmunity, InnateInfant, NewbornLungLymphocytesMicePregnancyCytokinesbronchopulmonary dysplasiaIL-17IL-22ILC3NKP46−ILC3

Identifiers

PMID35122179
PMCPMC8956536
OpenAlexW4210667876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.